Disc Medicine, Inc.
Developing novel therapies for patients with serious hematologic and rare blood disorders.
IRON | NDAQ
Overview
Corporate Details
- ISIN(s):
- US36870G1058 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 321 ARSENAL STREET, SUITE 101, 2472 WATERTOWN
- Website:
- https://www.discmedicine.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases. The company focuses on translating scientific discoveries into impactful therapies for a range of conditions, from rare blood disorders to widespread, chronic diseases. Its development pipeline is built on pioneering new fields of biology to create first-in-class treatments. A key candidate in its portfolio is bitopertin, a therapy developed for erythropoietic protoporphyria (EPP), for which the company has submitted a New Drug Application.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Disc Medicine, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Disc Medicine, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Disc Medicine, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
